申请人:Université Laval
公开号:US20150225423A1
公开(公告)日:2015-08-13
The present invention features compounds having the Formula (Ia) and (Ib) (e.g., a compound of any of Formulas ((Ia-2)-(Ia-21)), including other tautomers, stereoisomers, E/Z stereoisomers, prodrugs, pharmaceutically acceptable salts, and compositions thereof. The invention also features methods for treating or preventing pain (e.g., neuropathic pain), inflammation, or epilepsy in a patient by administering an effective amount of a compound of Formula (Ia) or (Ib). The invention also features a method for treating or preventing pain (e.g., neuropathic pain), inflammation, or epilepsy in a patient that includes administering to a patient in need thereof an effective amount of a compound of Formula (IIa) or (IIb) (e.g., a compound of any of Formulas ((IIa-2)-(IIa-6)). The compounds described herein (e.g., a compound of Formulas (Ia), (Ib), (IIa), or (IIb)) can also be used as anticonvulsants.
本发明涉及具有式(Ia)和(Ib)的化合物(例如,任何公式((Ia-2)-(Ia-21))的化合物,包括其他互变异构体、立体异构体、E/Z立体异构体、前药、药学上可接受的盐及其组合物。本发明还涉及通过给患者施用式(Ia)或(Ib)的化合物的有效量来治疗或预防疼痛(例如,神经痛)、炎症或癫痫的方法。本发明还涉及一种治疗或预防疼痛(例如,神经痛)、炎症或癫痫的方法,包括向需要的患者施用式(IIa)或(IIb)的化合物的有效量(例如,任何公式((IIa-2)-(IIa-6))的化合物)。本文所描述的化合物(例如,公式(Ia)、(Ib)、(IIa)或(IIb)的化合物)也可用作抗惊厥剂。